Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00388050 · ClinicalTrials.gov registry record · NA
Diabetes Medication Choice
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 85
- Enrollment target
NCT00388050: Completed NA study, sponsored by Mayo Clinic.
NCT00388050 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 85 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00388050, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 85 participants
- Enrollment target
Study Summary
The purpose of this study is to examine how different ways of sharing information about diabetes medication treatment options with patients can affect their choices and health.
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL Diabetes Medication Choice decision aid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2006-07 |
| Est. Completion | 2008-10 |
| Phase | NA |
What the finished NCT00388050 record still lists
NCT00388050 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 85 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT00388050 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00388050 about?
NCT00388050 is a clinical study titled "Diabetes Medication Choice". The purpose of this study is to examine how different ways of sharing information about diabetes medication treatment options with patients can affect their choices and health.
What is the current status of trial NCT00388050?
This trial is currently completed. It is a NA study. The enrollment target is 85 participants. The study started on 2006-07. Estimated completion is 2008-10.
What interventions are being tested in trial NCT00388050?
The interventions under investigation include: Usual Care (BEHAVIORAL), Diabetes Medication Choice decision aid (BEHAVIORAL).
Who is sponsoring clinical trial NCT00388050?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00388050's enrollment target sits among peer trials
85 980th of 2000 higher than 1,018 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00842283 · 85 participants
Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target
- NCT02133196 · 85 participants · Phase 2
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
- NCT03823144 · 85 participants · NA
Intravital Microscopy in Human Solid Tumors
- NCT03875638 · 85 participants · Phase 2
Treating Hyperexcitability in AD With Levetiracetam
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia